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A B S T R A C T
The incidence of tuberculosis in humans due to Mycobacterium caprae is very low and is almost conﬁned
to Europe. We report a case of a previously healthy 41-year-old Moroccan with a 6 month history of
abdominal pain, weight loss, fatigue and diarrhea. A diagnosis of peritoneal tuberculosis due to M. caprae
was made.
 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Peritoneal tuberculosis is an uncommon site of extrapulmonary
infection in industrialized countries caused by Mycobacterium
tuberculosis complex. The diagnosis can be challenging, since the
most common ﬁndings are nonspeciﬁc, and a high index of suspicion
is required to make the diagnosis in a timely manner. Mycobacterium
caprae causes tuberculosis in humans and animals, but the incidence
in humans is very low worldwide [1]. To our knowledge, we report
the ﬁrst case of peritoneal tuberculosis caused by M. caprae.
Case report
A 41-year-old Moroccan male, who had been living in Spain for
7 years, was admitted to the rapid diagnosis unit of Internal
Medicine of the Complejo Asistencial Universitario de Leo´n, Spain
with a 6 month history of abdominal pain, weight loss (10 kg in
two months), fatigue and diarrhea. The patient had no relevant
past medical history. He lived in an urban area, working as an
electrician, and had no reported animal contact and denied
ingesting unpasteurized dairy products.* Corresponding author at: Servicio de Microbiologı´a, Complejo Asistencial
Universitario de Leo´n, Avda. Altos de Nava s/n, Leo´n, Spain. Tel.: +34 606184089;
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4.0/).A depressible, soft and painless abdomen was revealed on
examination with diffuse discomfort on palpation and no signs of
guarding. Laboratory tests showed a normal white blood cell count
and a normocytic anemia. A HIV antibody test was negative.
Mantoux test (17 mm) and interferon g release assays were both
positive. Chest X-ray and chest CT scan were normal and an
abdominal CT scan showed mild ascites with small bilateral
inguinal lymphadenopathy.
An intense plastic peritonitis was encountered at laparoscopy
affecting all abdominal spaces with soft rubbery adhesions that
virtually blocked all initial access to the abdominal cavity.
Countless amount of nodules were seen on the omentum and
both the parietal and the visceral peritoneum and mainly on
Glisson’s sheath and digestive tube serosal surfaces (Fig. 1). A small
amount of ﬂuid was observed around liver and spleen. Careful
adhesiolysis was needed for exposure and to obtain ﬂuid samples.
Various biopsies were taken from the omental and peritoneal
nodules. All specimens were sent for microbiology, cytology and
pathological examinations. Histopathology showed non-necrotiz-
ing granuloma. Acid fast stains of the tissue were negative. There
was no evidence of malignancy. No acid fast bacilli (AFB) were seen
on stain of the peritoneal ﬂuid. The ﬂuid PCR and culture were also
negative for mycobacteria.
Mycobacterial DNA was identiﬁed in the biopsy by PCR (Xpert1
MTB/Rif PCR, Cepheid AB, Solna, Sweden). Mycobacterial growth
was detected with BactecTM MGITTM 960 system, (Bectone under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
Fig. 1. Nodules and peritoneal adhesions seen at laparoscopy.
Table 1
Members of the Mycobacterium tuberculosis complex.
Microorganism Primary host(s)
Mycobacterium tuberculosis Man
Mycobacterium africanum Man (West Africa)
Mycobacterium canettii Man (Horn of Africa)
Mycobacterium bovis Cattle and other animals
Mycobacterium bovis BCG Vaccine
Mycobacterium microti Voles and other small rodents
Mycobacterium caprae Goats, cattle and other animals (Europe)
Mycoabcterium pinnipedii Seals
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Immunochromatographic test for MTC (TB Ag MPT 64 rapid,
Standard diagnostics, INC, Republic of Korea) classiﬁed this isolate
within the M. tuberculosis complex. Identiﬁcation and susceptibility
testing were performed as described [2] at the National de
Mycobacterium laboratory, Instituto Carlos III, Majadahonda, Madrid,
Spain as M. caprae being fully sensitive to isoniazid, streptomycin,
ethambutol, rifampin and pyrazinamide. The M. caprae isolate
corresponded to spoligotype SIT646 in the international SITVIT
database and SB0416 in the Mycobacterium bovis spoligotype
database (http://www.Mbovis.org). It was performed Aragon Insti-
tute for Health Research (IIS Aragon), Zaragoza, Spain as previous
described [3].
Treatment for tuberculous peritonitis was initiated after the
laparoscopy with a 4-drug regimen of including isoniazid,
rifampin, pyrazinamide and ethambutol. Two months after
starting antituberculous treatment, the patient reported improve-
ment of symptoms. The patient completed 2 months of four-drug
therapy without complications and an additional 7 months of
isoniazid and rifampin. He is asymptomatic.
Discussion
M. caprae, a member of the M. tuberculosis complex (Table 1) can
cause tuberculosis in man and many domesticated and wild
animals. The organism was ﬁrst characterized in 1999 and the
name M. tuberculosis subspecies caprae was proposed [4]. In 2003,
it was elevated to species rank as M. caprae [5]. Zoonotic
transmission of this bacterium from livestock, mainly goats or
cattle, to man seems to be the major route of human acquisition
and no clear evidence of man-to-man transmission has been
reported.
The incidence of infection with M. caprae in humans does not
exceed 0.3% of total tuberculosis cases and is almost entirely
conﬁned to Europe. This low incidence is due to public health
measures introduced decades ago to prevent zoonotic tuberculosistransmission in industrialized nations: pasteurization of dairy
products and culling of infected cattle herds [1]. Although, zoonotic
tuberculosis in some European countries has increased recently
due to the migration of people from areas more endemic for
M. bovis, this does not seem to be the case for infection with
M. caprae as most infected individuals have been native Europeans
[1,6]. Outside Europe, M. caprae has been reported in only 1 human
case in Morocco [7] and in 3 cattle cases (2 cases in Algeria and
1 case in Tunisia) [1]. The Morocco isolate showed spoligotype
SIT644 [7].
In Spain, M. caprae is widespread in domesticated goats and
cattle and in a variety of wild animals, representing 7.4% of all M.
tuberculosis complex isolates from animals [8]. The percentage of
human M. tuberculosis complex infections, however, is low, about
0.3% [2]. Althought SB0157 is the most dominant spoligotype, both
in humans and animals, the SB0416 spoligotype found in our
patient is the second most common in animals in our region [8] and
have seen isolated in humans in other regions of Spain, in Germany
and in Austria [1], so it is likely that the infection was acquired in
Spain.
Du¨rr et al. [9] found a strong association between zoonotic
tuberculosis and extrapulmonary diseases as compared to non-
zoonotic human tuberculosis with, being lymph nodes and
genitourinary systems the most often affected primary sites. In
European countries, patients with zoonotic tuberculosis suffered
more from reactivation of old infections, which mainly leads to
pulmonary tuberculosis. This could explain that only few cases due
to M. caprae have been reported in detail in case reports: 2 cases of
cuateous tuberculosis [10,11] and 1 each of pericarditis case [12],
urinary tract involvement [13] and meningitis [14].
A high rate of tuberculosis is reported in Leon’s Health Area
with an incidence of active tuberculosis in 2013 of 18 per
100.000 populations as [12] compared with Spain’s overall rate of
12 per 100.000 [15]. Tubercular peritonitis is very uncommon with
only 6 cases of abdominal tuberculosis of a total of 596 cases of TB
have been conﬁrmed in our laboratory between 2006 and 2015;
ﬁve of them were native people unlike others European studies in
which a higher proportion of peritoneal tuberculosis in immigrant
populations from developing countries is found [16,17].
In low incidence countries, the diagnosis of peritoneal
tuberculosis is often delayed for more than 4 months or even
overlooked [16,17], partly due to a nonspeciﬁc clinical presenta-
tion in the absence of lung involvement and in part because more
than 20% of patients do not have risk factors with nonspeciﬁc
laboratory tests [17]. The diagnosis in our patient was made
following 6 months of symptoms.
Laparoscopy is the gold standard for diagnosis of peritoneal
tuberculosis, yielding the diagnosis in up to 92% of cases [16]. It
permits a complete exploration of the peritoneal cavity and allows
the ability to sample various tissues for biopsy and culture.
Peritoneal tuberculosis is a paucibacillar process and is rarely
possible to demonstrate acid-fast bacilli in ascitic ﬂuid. In this case,
as reﬂected in the literature, AFB stain, PCR and culture did not
assist in the initial management of the patient [16].
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